Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 71 - 80 out of 121

AMIA Response to CMS Stage 3 Open Comment Period

December 14, 2015

On December 14, AMIA submitted comments to CMS regarding the need to redesign Meaningful Use (MU) in the face of changing reimbursement models.  Specifically, AMIA asked regulators to change MU requirements to better align with programs required by the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.

Food and Drug Administration Safety and Innovation Act (FDASIA)

July 7, 2014

AMIA Comments on Proposed Risk-Based Regulatory Framework and Strategy for Health Information Technology Report

On behalf of the American Medical Informatics Association (AMIA), I am pleased to submit these comments in response to the above-referenced request. AMIA is the professional home for biomedical and health informatics and is dedicated to […]

AMIA Letter to HITPC on Population Health Objectives

March 3, 2014

Dr. Paul Tang
Chair, Meaningful Use Working Group and Health IT Policy Committee (HITPC)
Office of the National Coordinator for Health Information Technology
Department of Health and Human Services
Hubert H. Humphrey Building
200 Independence Ave. SW
Washington, DC 20201

Public and Population Health in Stage 3 of Meaningful Use […]